Health-related quality of life in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation with tyrosine kinase inhibitors treatment: a systematic review
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.